Terms ending in 2034
Every in-force patent on Standard Biotools Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,220,702 | Method and Systems for Microfluidic Logic Devices In force · High confidence | Standard Biotools Inc. | In force | High confidence | |
| US 9,809,848 | Simultaneous Detection of Target Protein and Target Nucleic Acids in a Single Cell In force · High confidence | Standard Biotools Inc. | In force | High confidence | |
| US 10,214,773 | Simultaneous Detection of Target Protein and Target Nucleic Acids in a Single Cell In force · High confidence | Standard Biotools Inc. | In force | High confidence | |
| US 10,578,633 | Methods and Devices for Analysis of Defined Multicellular Combinations In force · High confidence | Standard Biotools Inc. | In force | High confidence | |
| US 10,241,023 | Sample Analysis for Mass Cytometry In force · Medium confidence | Standard Biotools Canada Inc. | In force | Medium confidence | |
| US 11,630,050 | Sample Analysis for Mass Cytometry In force · Medium confidence | Standard Biotools Canada Inc. | In force | Medium confidence | |
| US 11,400,450 | Method and Systems for Microfluidic Logic Devices In force · High confidence | Standard Biotools Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.